Myeloid sarcoma (MS) is a very rare disease in both adults and children. Prognosis is poor in adults; in the pediatric age, the prognostic impact of extramedullary disease is controversial. Systemic therapy represents the mainstay of treatment even in isolated MS, but a comparison between different induction regimens is very limited in the literature. To date, it is still not clear if induction treatment should differ from that of other acute myeloid leukemias and stem cell transplant is considered for consolidation in both leukemic patients and in those with isolated disease. Our study describes a retrospective series of 13 cases of MS (adults and children), diagnosed and treated at our institute over 18 years. We report the results of immunophenotypic, cytogenetic and molecular studies, therapeutic approaches, and outcome, in order to establish the best strategy for patients’ workup.

1.
Arber
DA
,
Orazi
A
,
Hasserjian
R
,
Thiele
J
,
Borowitz
MJ
,
Le Beau
MM
,
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
.
Blood
.
2016
;
127
(
20
):
2391
405
. .
2.
Tsimberidou
AM
,
Kantarjian
HM
,
Wen
S
,
Keating
MJ
,
O'Brien
S
,
Brandt
M
,
Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia
.
Cancer
.
2008
;
113
:
1370
8
. .
3.
Samborska
M
,
Derwich
K
,
Skalska-Sadowska
J
,
Kurzawa
P
,
Wachowiak
J
.
Myeloid sarcoma in children – diagnostic and therapeutic difficulties
.
Contemp Oncol
.
2016
;
20
:
444
8
. .
4.
Kawamoto
K
,
Miyoshi
H
,
Yoshida
N
,
Takizawa
J
,
Sone
H
,
Ohshima
K
.
Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients
.
Am J Surg Pathol
.
2016
;
40
:
1473
83
. .
5.
Shahin
OA
,
Ravandi
F
.
Myeloid sarcoma
.
Curr Opin Hematol
.
2002
;
27
:
88
94
. .
6.
Dusenbery
KE
,
Howells
WB
,
Arthur
DC
,
Alonzo
T
,
Lee
JW
,
Kobrinsky
N
,
Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children’s Cancer Group
.
J Pediatr Hematol Oncol
.
2003
;
25
:
760
8
. .
7.
Burnett
A
,
Wetzler
M
,
Löwenberg
B
.
Therapeutic advances in acute myeloid leukemia
.
J Clin Oncol
.
2011
;
29
:
487
94
. .
8.
Döhner
H
,
Estey
E
,
Grimwade
D
,
Amadori
S
,
Appelbaum
FR
,
Büchner
T
,
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
.
Blood
.
2017
;
129
:
424
47
. .
9.
Ullman
DI
,
Dorn
D
,
Jones
JA
,
Fasciano
D
,
Ping
Z
,
Kanakis
C
,
Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia
.
Histopathology
.
2019
;
75
:
185
92
. .
10.
Pramanik
R
,
Tyagi
A
,
Chopra
A
,
Kumar
A
,
Vishnubhatla
S
,
Bakhshi
S
.
Myeloid sarcoma predicts superior outcome in pediatric AML; can cytogenetics solve the puzzle?
Clin Lymphoma Myeloma Leuk
.
2018
;
18
:
e249
54
.
11.
Guanhua
H
,
Aidong
L
,
Jun
W
,
Jia
Y
,
Zuo
Y
,
Ding
M
,
Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21)
.
Pediatr Hematol Oncol
.
2020
;
17
:
1
11
.
12.
Tsimberidou
AM
,
Kantarjian
HM
,
Estey
E
,
Cortes
JE
,
Verstovsek
S
,
Faderl
S
,
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy
.
Leukemia
.
2003
;
17
:
1100
3
. .
13.
Antic
D
,
Elezovic
I
,
Milic
N
,
Suvajdzic
N
,
Vidovic
A
,
Perunicic
M
,
Is there a “gold” standard treatment for patients with isolated myeloid sarcoma?
Biomed Pharmacother
.
2013
;
67
:
72
7
. .
14.
Ofran
Y
,
Rowe
JM
.
Induction and postremission strategies in acute myeloid leukemia: what is new?
Curr Opin Hematol
.
2011
;
18
:
83
8
. .
15.
Stölzel
F
,
Röllig
C
,
Radke
J
,
Mohr
B
,
Platzbecker
U
,
Bornhäuser
M
,
18-F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia
.
Haematologica
.
2011
;
96
:
1552
6
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.